eFFECTOR Therapeutics, Inc.

EFTROTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$941

P/E Ratio—

52W High$0.01

52W Low$0.0002

Avg Volume2K

Open$0.00

Beta2.40

Earnings Financials Revenue

eFFECTOR Therapeutics, Inc. (EFTR) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

EFTR · earnings · updated Jun 8, 2026

Latest Earnings

Q2 FY2024Report Date: May 9, 2024

EPS Actual

-$2.16

Est. -$2.17 · +0.5%

Revenue

—

Fiscal Period

Q2 FY2024

FY ends December

Report Date

May 9, 2024

After Market Close

✓ 1-Quarter EPS Beat Streak

EFTR reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Aug 12, 2026	-$6.40	—	—	—	$0.00B	—
◌ Q3 FY2026	Aug 12, 2026	-$6.40	—	—	—	$0.00B	—
◌ Q1 FY2026	Mar 24, 2026	-$6.40	—	—	—	—	—
◌ Q4 FY2025	Oct 27, 2025	—	—	—	—	—	—
◌ Q3 FY2025	Aug 7, 2025	—	—	—	—	—	—
◌ Q2 FY2025	May 30, 2025	-$2.02	—	—	—	—	—
◌ Q1 FY2025	Feb 28, 2025	-$2.02	—	—	—	—	—
◌ Q4 FY2024	Nov 14, 2024	—	—	—	—	—	—

Q3 FY2026

Aug 12, 2026

EPS Actual

—

EPS Est.

-$6.40

EPS Surpr.

—

Revenue

—

Q3 FY2026

Aug 12, 2026

EPS Actual

—

EPS Est.

-$6.40

EPS Surpr.

—

Revenue

—

Q1 FY2026

Mar 24, 2026

EPS Actual

—

EPS Est.

-$6.40

EPS Surpr.

—

Revenue

—

Q4 FY2025

Oct 27, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2025

Aug 7, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2025

May 30, 2025

EPS Actual

—

EPS Est.

-$2.02

EPS Surpr.

—

Revenue

—

Q1 FY2025

Feb 28, 2025

EPS Actual

—

EPS Est.

-$2.02

EPS Surpr.

—

Revenue

—

Q4 FY2024

Nov 14, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q3 FY2029	$-0.87	$-0.87	$-0.87	1
Q2 FY2029	$-1.95	$-1.95	$-1.95	1
Q1 FY2029	$-2.02	$-2.02	$-2.02	1
Q4 FY2028	$-2.17	$-2.17	$-2.17	1
Q3 FY2028	$-2.82	$-2.82	$-2.82	1
Q2 FY2028	$-3.08	$-3.08	$-3.08	1

Revenue Estimates

Period	Low	Consensus	High
Q3 FY2029	$0.0B	$0.0B	$0.0B
Q2 FY2029	$0.0B	$0.0B	$0.0B
Q1 FY2029	$0.0B	$0.0B	$0.0B
Q4 FY2028	$0.0B	$0.0B	$0.0B
Q3 FY2028	$0.0B	$0.0B	$0.0B
Q2 FY2028	$0.0B	$0.0B	$0.0B

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▲ Q2 FY2024	May 9, 2024	+0.5%	$2.08	$2.14	+2.88%
▼ Q1 FY2024	Mar 25, 2024	-25.3%	$12.33	$13.76	+11.60%
▲ Q4 FY2023	Nov 13, 2023	+0.0%	$14.75	$13.95	-5.42%

Q2 FY2024+2.88%

Report Date

May 9, 2024

EPS Beat/Miss

+0.5%

Price Before

$2.08

Price After

$2.14

Q1 FY2024+11.60%

Report Date

Mar 25, 2024

EPS Beat/Miss

-25.3%

Price Before

$12.33

Price After

$13.76

Q4 FY2023-5.42%

Report Date

Nov 13, 2023

EPS Beat/Miss

+0.0%

Price Before

$14.75

Price After

$13.95

Avg Beat Reaction-1.27%

Avg Miss Reaction+11.60%

Beat Rate2 / 3 quarters

Largest Move+11.60% (Q1 FY2024)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

eFFECTOR Therapeutics, Inc. (EFTR) most recently reported earnings on May 9, 2024 for Q2 FY2024, posting EPS of $-2.16 (in line with the analyst consensus of $-2.17). The next EFTR earnings date is expected around September 1, 2026.

Each quarter, investors track EFTR earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EFTR revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

EFTR's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

EFTR earnings · 4 questions

eFFECTOR Therapeutics, Inc.'s next earnings report is expected around September 1, 2026. EFTR typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EFTR historically reports after market close (AMC).

EFTR earnings datewhen is EFTR earningsEFTR next earnings datewhen does EFTR report earningsEFTR earnings calendar

▸ Source: FMP · eFFECTOR Therapeutics, Inc. SEC filings · US GAAP · eFFECTOR Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026